Skip to main content

Spectrum Vascular to Acquire Assets of AngioDynamics

Press releases | February 14, 2024

Fried Frank represented Event Capital Strategies in the acquisition by its portfolio company, Spectrum Vascular, of certain assets, including the PICC and Midline product portfolios, of AngioDynamics, Inc., a leading medical technology company.

The Fried Frank team was led by partner Steven Epstein. 


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.